A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma

N6-methyladenosine (m6A) and long non-coding RNA (lncRNA) have been associated with cancer prognosis and the effect of immunotherapy. However, the roles of m6A-related lncRNAs in the prognosis and immunotherapy in lung adenocarcinoma (LUAD) patients remain unclear. We evaluated the m6A modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yefeng, Wang, Shaochun, Wu, Yuanzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368324/
https://www.ncbi.nlm.nih.gov/pubmed/35954243
http://dx.doi.org/10.3390/cells11152399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368324/
https://www.ncbi.nlm.nih.gov/pubmed/35954243
http://dx.doi.org/10.3390/cells11152399

Ejemplares similares